Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
Clinical trial NCT01626391 · TERMINATED
Trial details
- NCT number
- NCT01626391
- Sponsor
- TauRx Therapeutics Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.